Investor Guide to Oncology

The research division of OneMedPlace has produced a quarterly Investor Guide to Oncology. This guide features our editorial series on […]

Read more »

Jack Young, Qualcomm Life Sciences Director, Discusses Mobile Health and Patient Management

Young’s experience in both sectors makes him a unique voice in the osmosis of venture capital between mobile technology and life sciences. Young will participate in a panel dedicated to the subject at the 6th Annual OneMedForum in San Francisco, January 7-9. OneMedRadio spoke with Jack Young about investing in this sector, and the points of significant unmet medical need which represent the most promising opportunities.

Read more »

`OneMedForum` Panel to Address the Major Opportunities in Digital Health at San Francisco Conference

OneMedPlace announced today that Peter Neupert of Health Evolution Partners and Jack Young of Qualcomm Ventures will participate in programming for the 6th Annual OneMedForum, January 7-9, 2013, in San Francisco. The two experts will take part in a panel dedicated to ‘Digital and Connected Health,’ an emerging sector with significant and diverse investment opportunities.

Read more »

OneMedRadio: Immune Pharmaceuticals CEO and Epicept Corporation CEO Discuss Merger

Last week, OneMedRadio spoke with Immune Pharmaceuticals founder and CEO Dr. Daniel Teper and Epicept Corporation President and CEO Robert Cook, to discuss the merger and the clinical focus of the merged company going forward.

Read more »

Smart Stocks Watch: Atossa Genetics — FDA-Approved Diagnostic Test for Breast Cancer

Atossa Genetics [Nasdaq: ATOS] is a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer through the detection of precursors to breast cancer.

Read more »